Dr. Matthew Koopmann, MD
Claim this profileVA Portland Health Care System
Studies Aortic Aneurysm
Studies Abdominal Aortic Aneurysm
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Matthew Koopmann, MD is currently running
Nectero EAST System
for Abdominal Aortic Aneurysm
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Recruiting1 award Phase 2 & 39 criteria
Stent Graft Systems
for Abdominal Aortic Aneurysm
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
Recruiting1 award N/A5 criteria
More about Matthew Koopmann, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Matthew Koopmann, MD has experience with
- Vorapaxar
- Placebo
- FDA Approved EVAR AAA Graft Systems
- Alto Abdominal Stent Graft System
- Nectero EAST System
Breakdown of trials Matthew Koopmann, MD has run
Aortic Aneurysm
Abdominal Aortic Aneurysm
Peripheral Vascular Disease
Peripheral Arterial Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Koopmann, MD specialize in?
Matthew Koopmann, MD focuses on Aortic Aneurysm and Abdominal Aortic Aneurysm. In particular, much of their work with Aortic Aneurysm has involved treating patients, or patients who are undergoing treatment.
Is Matthew Koopmann, MD currently recruiting for clinical trials?
Yes, Matthew Koopmann, MD is currently recruiting for 2 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Matthew Koopmann, MD has studied deeply?
Yes, Matthew Koopmann, MD has studied treatments such as Vorapaxar, Placebo, FDA Approved EVAR AAA Graft Systems.
What is the best way to schedule an appointment with Matthew Koopmann, MD?
Apply for one of the trials that Matthew Koopmann, MD is conducting.
What is the office address of Matthew Koopmann, MD?
The office of Matthew Koopmann, MD is located at: VA Portland Health Care System, Portland, Oregon 97239 United States. This is the address for their practice at the VA Portland Health Care System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.